Accessibility Menu
 
Novacyt logo

Novacyt

(LSE) NCYT

Current Price$33.00
Market Cap$2.40B
Since IPO (2017)-45%
5 Year-92%
1 Year-19%
1 Month+0%

Novacyt Financials at a Glance

Market Cap

$2.40B

Revenue (TTM)

$34.29M

Net Income (TTM)

$47.63M

EPS (TTM)

$-43.04

P/E Ratio

-0.77

Dividend

$0.00

Beta (Volatility)

-0.20 (Low)

Price

$33.00

Volume

76,771

Open

$31.90

Previous Close

$33.00

Daily Range

$30.80 - $33.14

52-Week Range

$30.80 - $54.00

NCYT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novacyt

Industry

Biotechnology

CEO

Lyn Dafydd Rees

Headquarters

Le Vésinet, 78140, FR

NCYT Financials

Key Financial Metrics (TTM)

Gross Margin

66%

Operating Margin

-73%

Net Income Margin

-65%

Return on Equity

-50%

Return on Capital

-13%

Return on Assets

-10%

Earnings Yield

-1.30%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.40B

Shares Outstanding

72.59M

Volume

76.77K

Short Interest

0.00%

Avg. Volume

45.53K

Financials (TTM)

Gross Profit

$32.07M

Operating Income

$37.34M

EBITDA

$34.31M

Operating Cash Flow

$9.15M

Capital Expenditure

$1.86M

Free Cash Flow

$11.01M

Cash & ST Invst.

$30.46M

Total Debt

$11.88M

Novacyt Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$9.98M

+20.3%

Gross Profit

$3.25M

+447.7%

Gross Margin

32.61%

N/A

Market Cap

$2.40B

N/A

Market Cap/Employee

$10.24M

N/A

Employees

234

N/A

Net Income

$3.17M

+84.2%

EBITDA

$4.50M

+56.1%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$11.00M

-63.8%

Accounts Receivable

$5.35M

+4875.5%

Inventory

$2.98M

-1.4%

Long Term Debt

$10.01M

-19.9%

Short Term Debt

$2.07M

+71.4%

Return on Assets

-10.01%

N/A

Return on Invested Capital

-12.62%

N/A

Free Cash Flow

$2.83M

+42.4%

Operating Cash Flow

$5.24M

-15.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CREO.LCreo Medical Limited
$11.75+8.05%
AOTI.LAOTI, Inc.
$38.50+2.67%
POLB.LPoolbeg Pharma PLC
$4.20+0.00%
AREC.LArecor Therapeutics plc
$64.50+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$128.06-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
CRWVCoreWeave
$102.00+0.11%
NOKNokia
$9.46-0.01%

Questions About NCYT

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.